Health
-
FDA Approves Penpulimab-kcqx for Advanced Nasopharyngeal Cancer
The U.S. Food and Drug Administration (FDA) recently approved Penpulimab-kcqx. This groundbreaking monoclonal antibody that…
-
Ribociclib Gains New Ground in Early Breast Cancer Treatment
The National Institute for Health and Care Excellence (NICE) has recommended the use of Ribociclib…
-
Breakthrough Study Reveals Key Blood Proteins Predict MASLD Up to 16 Years in Advance
Recent research led by Shiyi Yu, MD, has identified five key blood proteins that can…
-
The Key to Longevity: Strengthening Immune Resilience in Midlife
New discoveries emphasize the need for immune resilience as a key variable in earning our…
-
Diabetes Medication Linked to Increased Fall Risk in Patients
A recent case-control study has found a strong connection between the use of sodium-glucose cotransporter…
-
FDA Approves Penpulimab for Treatment of Rare Head and Neck Cancer
The Penpulimab has been approved by U.S. Food and Drug Administration (FDA). This lab-produced antibody…
-
Measles on the Rise: Urgent Need for Vaccination to Prevent Endemic Status
According to a new study, things aren’t looking too good for measles in the United…
-
Exploring the Link Between Oral Microbiome and Migraines
Filling this gap is an area of research that connects the oral microbiome to migraine…
-
Predictive Factors Influence Guselkumab Efficacy in Psoriasis Treatment
Fortunately, a recent retrospective longitudinal study has provided helpful real-world evidence on the long-term efficacy…
-
New Insights on Pediatric MASLD Management Spark Hope for Young Patients
Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is rapidly becoming the most common cause of…
About Author
Alex Lorel
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua veniam.
